Confounding Factors in Treatment-Resistant Depression (Part 2): Comorbidities and Treatment Resistance

by Michael I. Casher, MD, Daniel Gih, MD, Joshua D. Bess, MD,
and Prachi Agarwala, MD | August 3, 2012

Dr Casher is Director, Psychiatry Adult Inpatient Program, and Clinical Assistant Professor, department of psychiatry, University of Michigan Medical School, Ann Arbor. Dr Gih is Clinical Assistant Professor, Attending, Child and Adolescent Inpatient Psychiatry, University of Michigan Medical School. Dr Bess is Clinical Instructor, At-tending, Adult Inpatient Psychiatry, University of Michigan Medical School. Dr Agarwala is Child and Ado-lescent Psychiatry Hospitalist, Fairview Health Services, Minneapolis. Drs Casher and Bess are co-authors of Manual of Inpatient Psychiatry (Cambridge University Press, 2010), reviewed in Psychiatric Times, February 2011. Dr Casher reports that he is on the Speakers Bureau for Sunovion Pharmaceuticals and AstraZeneca. Drs Casher and Bess receive royalties from Cambridge University Press. Drs Gih, Bess, and Agarwala report no conflicts concerning the subject matter of this article.

Answer key to the Mine Your Mind posttest:

1, D; 2, C; 3, B; 4, B; 5, B; 6, A; 7, B; 8, D; 9, C; 10, A.

Pages: 1 2 3 4 5 6 7 8 9

Confounding Factors in Treatment-Resistant Depression (Part 2): Comorbidities and Treatment Resistance

Treatment Resistance and Patient Authority: The Austen Riggs Reader

References

1. Barbee JG. Treatment-resistant depression: advances in assessment. Psychiatr Times. 2008;25(10):20-22.

2. Casher MI, Gih D, Bess JD, Agarwala P. Confounding factors in TRD (Part 1): the role of subtyping and bipolarity. Psychiatr Times. 2012;29(7):36-38.

3. Moffitt TE, Harrington H, Caspi A, et al. Depression and generalized anxiety disorder: cumulative and sequential comorbidity in a birth cohort followed prospectively to age 32 years. Arch Gen Psychiatry. 2007;64:651-660.

4. Rapaport MH. Prevalence, recognition, and treatment of comorbid depression and anxiety. J Clin Psychiatry. 2001;62(suppl 24):6-10.

5. Kornstein SG, Schneider RK. Clinical features of treatment-resistant depression. J Clin Psychiatry. 2001;62(suppl 16):18-25.

6. Pollack MH. Comorbid anxiety and depression. J Clin Psychiatry. 2005;66(suppl 8):22-29.

7. Petersen T, Gordon JA, Kant A, et al. Treatment resistant depression and axis I co-morbidity. Psychol Med. 2001;31:1223-1229.

8. Fawcett J. The detection and consequences of anxiety in clinical depression. J Clin Psychiatry. 1997;58(suppl 8):35-40.

9. Kessler RC, Nelson CB, McGonagle KA, et al. Comorbidity of DSM-III-R major depressive disorder in the general population: results from the US National Comorbidity Survey. Br J Psychiatry Suppl. 1996 Jun;(30):17-30.

10. Andreescu C, Lenze EJ, Dew MA, et al. Effect of comorbid anxiety on treatment response and relapse risk in late-life depression: controlled study. Br J Psychiatry. 2007;190:344-349.

11. Silverstone PH, Salinas E. Efficacy of venlafaxine extended release in patients with major depressive disorder and comorbid generalized anxiety disorder. J Clin Psychiatry. 2001;62:523-529.

12. Bernstein EM, Putnam FW. Development, reliability, and validity of a dissociation scale. J Nerv Ment Dis. 1986;174:727-735.

13. Saxe GN, van der Kolk BA, Berkowitz R, et al. Dissociative disorders in psychiatric inpatients. Am J Psychiatry. 1993;150:1037-1042.

14. Marcum JM, Wright K, Bissell WG. Chance discovery of multiple personality disorder in a depressed patient by amobarbital interview. J Nerv Ment Dis. 1986;174:489-492.

15. Hauri PJ, Sateia M, eds. The International Classification of Sleep Disorders. Diagnostic and Coding Manual. 2nd ed. Westchester, IL: American Academy of Sleep Medicine; 2005.

16. Ohayon MM. The effects of breathing-related sleep disorders on mood disturbances in the general population. J Clin Psychiatry. 2003;64:1195-1200.

17. Godart NT, Perdereau F, Rein Z, et al. Comorbidity studies of eating disorders and mood disorders: critical review of the literature. J Affect Disord. 2007;97:37-49.

18. Presnell K, Stice E, Seidel A, Madeley MC. Depression and eating pathology: prospective reciprocal relations in adolescents. Clin Psychol Psychother. 2009;16:357-365.

19. Coughlin JW, Edwards R, Buenaver L, et al. Pain, catastrophizing, and depressive symptomatology in eating disorders. Clin J Pain. 2008;24:406-414.

20. Angst J, Gamma A, Rössler W, et al. Long-term depression versus episodic major depression: results from the prospective Zurich study of a community sample. J Affect Disord. 2009;115:112-121.

21. Woodside BD, Staab R. Management of psychiatric comorbidity in anorexia nervosa and bulimia nervosa. CNS Drugs. 2006;20:655-663.

22. Claudino AM, Hay P, Lima MS, et al. Antidepressants for anorexia nervosa. Cochrane Database Syst Rev. 2006;(1):CD004365.

23. Schellander R, Donnerer J. Antidepressants: clinically relevant drug interactions to be considered. Pharmacology. 2010;86:203-215.

24. Benton T, Staab J, Evans DL. Medical co-morbidity in depressive disorders. Ann Clin Psychiatry. 2007;19:289-303.

Confounding Factors in Treatment-Resistant Depression (Part 2): Comorbidities and Treatment Resistance

Join the Conversation